Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0001179110-15-006459

Options or other derivatives

  • President and CEO acquired 87,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kumar Ramesh · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-04-16 Grant or award : show line 1 in the form Stock Option (right to buy) +87,500 $2.32 2025-04-16 87,500 87,500 D
Loading xslF345X03/edgar.xml…